Published this month in Supportive Care Cancer, we report on the implementation of a nurse led program sending patients at low risk of medical complications from neutropenic fever following chemo, home, to be managed in an outpatient setting.
Read the full study HERE
Our results show a reduction in median length of hospital stay from 4.0 to 1.1 days and a reduction in admission cost from $8,580 to $2,360 with a net cost benefit of $71,895. Not to mention that there's "No Place Like Home".